Science Explorer Back to mapMap
Discussion
Researcher · Lund University · Sweden

Per Jönsson

Per Jönsson publishes mostly in Pulmonary and Respiratory Medicine, Surgery and Oncology, on topics such as Lung Cancer Treatments and Mutations, Pancreatitis Pathology and Treatment and Cancer Genomics and Diagnostics.

ORCID 0000-0003-1597-5372 OpenAlex
World rank
#2,367,991
of 7,710,434 ranked researchers
Rank in Sweden
#30,532
of 71,437
Works
42
Citations
1.4k
Citations per work
32.9
h-index
19
i10-index 21Top 21% in Pulmonary and Respiratory Medicine
Per Jönsson

What does Per Jönsson research?

Per Jönsson's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 20 works · 47.7% of their workMedicine: 20 works · 47.7% of their workPulmonary and Respiratory Medicine: 10 works · 23.0% of their workSurgery: 4 works · 10.6% of their workOncology: 4 works · 9.7% of their workOrthopedics and Sports Medicine: 2 works · 4.4% of their workEverything else: 16 works · 37.3% of their workLife Sciences: 6 works · 15.0% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 15.0% of their workMolecular Biology: 4 works · 8.8% of their workCancer Research: 3 works · 6.2% of their workTHEIR WORKPer Jönsson42works
Life Sciences15%Health Sciences48%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2047.7%
  2. Everything else1637.3%
    1. Biochemistry, Genetics and Molecular Biology615.0%
  1. 1Pulmonary and Respiratory Medicine23% of their works
  2. 2Surgery11% of their works
  3. 3Oncology10% of their works
  4. 4Molecular Biology9% of their works
  5. 5Cancer Research6% of their works
  6. 6Orthopedics and Sports Medicine4% of their works

Research topics

Which keywords describe Per Jönsson's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Chemotherapy, Acute Pancreatitis, Chronic Pancreatitis and Cancer Genomics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy193 topics
  2. Clinical Trials142 topics
  3. ALK Inhibitors111 topic
  4. EGFR Mutations111 topic
  5. Chemotherapy82 topics
  6. Acute Pancreatitis61 topic
  7. Chronic Pancreatitis61 topic
  8. CT Screening51 topic
  9. Cancer Genomics51 topic
  10. Lung Cancer51 topic
  11. Mutational Signatures51 topic
  12. Cancer Stem Cells31 topic
  13. Copy Number Variation31 topic
  14. Genomic Profiles31 topic
  15. Genomic Rearrangements31 topic
  16. Neuroendocrine Tumors31 topic
  17. Pancreatic Neuroendocrine Tumors31 topic
  18. Small-Cell Lung Cancer31 topic
  19. Tumor Metastasis31 topic

Where does Per Jönsson work?

Per Jönsson's main affiliation in the publication record is Lund University, Sweden.

How many publications and citations does Per Jönsson have?

OpenAlex counts 42 works and 1,380 citations for Per Jönsson, an h-index of 19, ranking #2,367,991 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Per Jönsson

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Per Jönsson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.